26% characterized as below mild hemolysis). These PMCs have the potential to support the rapid growth of decentralized clinical testing by empowering patients to self-collect high-quality dried plasma samples.
No takes yet. Share an insight, caveat, or question.
Code et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: